1.
G Calabrese, D Fantasia, R Di Gianfilippo, L Stuppia, R Di Lorenzo, G Palka. Fluorescence in situ hybridization analysis of minimal residual disease and the relevance of the der(9) deletion in imatinib-treated patients with chronic myeloid leukemia. Haematologica 2006;91(7):994-995; https://doi.org/10.3324/%x.